Warren Buffet’s 4 financial ratios he checks before every investment. The thresholds are:
ROE >15%, Debt/Equity <0.5, Current Ratio >1.5, Operating or Profit Margin >15%.

Comparing Hartalega and Intco

Sources and dates used:

Hartalega (HARTA, KLSE:5168): Latest quarterly report for FPE 31 Dec 2025 (Q3 FY2026), released 10 Feb 2026. I pulled revenue, operating profit, net profit, equity, debt, current assets & liabilities directly from the QR. [docs.publicnow.com], [marketscreener.com]

INTCO Medical (SHE:300677): Latest TTM/ratio set as of Feb 2026 (ROE, D/E, current ratio) from S&P/StockAnalysis; margins corroborated with Yahoo Finance TTM line items. (INTCO’s next formal 2025 results are guided for Apr 24, 2026, so TTM is the freshest consolidated view now.) [stockanalysis.com], [finance.yahoo.com], [simplywall.st]

Computation:

Hartalega (QR for FPE 31 Dec 2025, released 10 Feb 2026)

Operating margin (Q3): 36,296 / 527,251 = 6.9%. [docs.publicnow.com]
Net margin (Q3): 31,671 / 527,251 = 6.0%. [docs.publicnow.com]
Debt/Equity: (Loans & borrowings: 6,654 LT + 594 ST = 7,248) / Equity (owners) 4,386,882 ≈ 0.00165×. [docs.publicnow.com]
Current ratio: Current assets 1,808,177 / Current liabilities 224,622 ≈ 8.05×. [docs.publicnow.com]
ROE (annualised run‑rate): 9M FY2026 NP 61,901 × (12/9) ≈ 82,535 / avg equity (~(4,318,931 + 4,386,568)/2) ≈ 1.9%. [docs.publicnow.com]

Interpretation: Hartalega’s balance sheet is extremely strong (nearly net-cash, very high liquidity), but current profitability is thin, so it fails the ROE and margin hurdles for now. [docs.publicnow.com]

INTCO Medical (latest TTM/ratios as of Feb 2026; quarterly detail pending next filing):

ROE: 9.84% TTM (S&P/StockAnalysis). [stockanalysis.com]
Debt/Equity: 0.96× (S&P/StockAnalysis). [stockanalysis.com]
Current ratio: 1.34× (S&P/StockAnalysis). [stockanalysis.com]
Operating margin (TTM): Operating income 1,089,361 / Revenue 9,849,586 ≈ 11.1% (Yahoo Finance). [finance.yahoo.com]
Net margin (TTM): Net income 1,702,420 / Revenue 9,849,586 ≈ 17.3% (Yahoo Finance). [finance.yahoo.com]

Interpretation: INTCO shows healthy net margin TTM but carries meaningful leverage and a sub‑1.5 current ratio, so it does not clear the D/E and liquidity bars. [stockanalysis.com]

In conclusion, bottom line vs the thresholds between Hartalega and Intco,

Hartalega:
Pass → Debt/Equity, Current Ratio
Fail → ROE 15%, Operating/Net margin 15% (at Q3 run‑rate) [docs.publicnow.com]

INTCO Medical:
Pass → Net margin 15% (TTM)
Fail → ROE 15%, D/E <0.5, Current Ratio >1.5, Operating margin 15% (TTM) [stockanalysis.com], [finance.yahoo.com]

TB outbreak: Mask up at crowded places like Ramadan bazaars, public urged. Take care everyone

Mask up in crowded areas – M’sia Records 503 New Tuberculosis Cases, Selangor Ranks 2nd Highest. Take care everyone

Viral outbreaks are always on the horizon – here are the viruses ...
In early 2026, health authorities are monitoring several, but not one single, "new world" virus. Key concerns include the rise of Chikungunya in the Americas, localized outbreaks of Nipah virus in Bangladesh and India, and a surge in New World screwworm cases in Mexico. Other watched, though not new, threats include Mpox and Measles and TB. Take care everyone

I will follow Harta management steer , they are a decent team with high integrity . Those disagree can agree to disagree I have no problem. May the market forces be with you, cheers !

Since 27 Jan 26, Harta has executed multiple open market share buybacks:
27 Jan : 1.6m shares at 0.885 - 0.89
28Jan: 1.35m shares at 0.93 - 0.945
29 Jan: additional buyback similar quantum
03 Feb: 0.33 shares at 0.895 -0.9

All shares were retained as treasury shares, not immediately cancelled
Cumulative treasury shares are now 17.6m shares (0.51%) of issued capital

This is deliberate, repeated intervention

The real signals:
Singal 1: Management believes the share price is undervalued. That tells you, at this level of price 0.88 to 0.95 using cash to buy own shares gives better return than alternative uses

This is stronger than verbal guidance and stronger than analyst reports

Signal 2: cash position is still strong
Harta can only legally fund buybacks from :
Retained earnings
Internal cash flow

The fact they are buying repeatedly implies:
No near term liquidity stress
No immediate capital call risk

This aligns with their net cash balance sheet profile despite weak sector conditions

Signal 3: dowmside protection is being actively defended

Repeated buybacks create:
A price floor
Reduced free float
Dampened panic selling

This is why the stock has somewhat stabilised despite sell calls from some brokers

What should you do as a Harta investor:
• if you are a long term investor
This behaviour is supportive not alarming
You should:
View RM0.88 to 0.95 as a management defended zone
Expect slow accumulation not V-shaped recovery
Be patient for 2026-2027 earnings normalisation

Bottom line
Harta is telling you with cash, not words:
This price is too low for our long term value and we are willing to buy our own shares repeatedly to prove it

Such a hopeless and helpless counter. MyNEWS, the name itself is already a lifeless word

Hopeless stock even with minister Johari Abdul Ghani on the board comparing with IAB having premier sister sat on the board it surged until limit up

与其去质疑别人不如你也一起多问AI几个‘为什么’，可能会发现些意想不到的角度，你要不要试试看呢？

对比两者之间的AI分析你觉得哪个比较靠谱呢？